p59sheLL
(Plasmid
#40628)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 40628 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonep5sheLL
-
Backbone manufacturerJ.T. Schiller, National Cancer Institute, Bethesda, MD, USA (http://home.ccr.cancer.gov/lco/default.asp)
- Backbone size w/o insert (bp) 7862
- Total vector size (bp) 10784
-
Modifications to backboneHPV5 L1 and L2 replaced with HPV59 L1 and L2
-
Vector typeMammalian Expression
-
Selectable markersZeocin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert 1
-
Gene/Insert nameHPV59 L1
-
Alt nameL1 major capsid protein
-
Alt nameL1
-
Alt nameHPV 59L1
-
SpeciesHuman Papillomavirus Type 59
-
Insert Size (bp)1527
-
MutationCodon optimized for mammalian expression
-
GenBank IDPlease see comments below
- Promoter CMV
Cloning Information for Gene/Insert 1
- Cloning method Restriction Enzyme
- 5′ cloning site BspEI (not destroyed)
- 3′ cloning site PspXI (not destroyed)
- 5′ sequencing primer CMV-F (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert nameHPV59 L2
-
Alt nameL2 minor capsid protein
-
Alt nameL2
-
Alt nameHPV 59L2
-
SpeciesHuman Papillomavirus Type 59
-
Insert Size (bp)1395
-
MutationCodon optimized for mammalian expression
-
GenBank IDPlease see comments below
- Promoter Polio IRES
Cloning Information for Gene/Insert 2
- Cloning method Restriction Enzyme
- 5′ cloning site NotI (not destroyed)
- 3′ cloning site NheI (not destroyed)
- 5′ sequencing primer Unknown
- 3′ sequencing primer WPRE-R (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Constructs representing HPV35 (p35sheLL), HPV39 (p39sheLL) and HPV59 (p59sheLL) were generated by the insertion of codon optimized genes (Blue Heron, Inc., Bothell, WA, USA) based upon consensus L1 and L2 amino acid sequences into p5shell (http://home.ccr.cancer.gov/lco/default.asp) The consensus sequences were derived from NCBI database sequences (HPV35: M74117, X74477; HPV39: M62849; HPV59: X77858, EU918767) and contemporary sequences from anonymous, HPVinfected cytology samples (HPV35 L1: JN104062–64; HPV35 L2: JN104065–67; HPV39 L1: JN104068–70; HPV39 L2: JN104071–72; HPV59 L1: JN104073–74; HPV59 L2: JN104075–77).
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
p59sheLL was a gift from Simon Beddows (Addgene plasmid # 40628 ; http://n2t.net/addgene:40628 ; RRID:Addgene_40628) -
For your References section:
Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera. Draper E, Bissett SL, Howell-Jones R, Edwards D, Munslow G, Soldan K, Beddows S. Vaccine. 2011 Nov 3;29(47):8585-90. Epub 2011 Sep 21. 10.1016/j.vaccine.2011.09.021 PubMed 21939712